Status:

RECRUITING

High-Intensity Exercise to Combat Vascular and Cognitive Dysfunction in Adults With HIV

Lead Sponsor:

University of Alabama at Birmingham

Conditions:

HIV

Arterial Stiffness

Eligibility:

All Genders

50+ years

Phase:

NA

Brief Summary

This is a single site, randomized exercise trial with individuals at least 50 years of age living with HIV who experience suboptimal cognition. The overall goals of this proposal are to determine whet...

Detailed Description

This is a single site, randomized exercise trial with individuals at least 50 years of age living with HIV who experience suboptimal cognition. The overall goals of this proposal are to determine whet...

Eligibility Criteria

Inclusion

  • Age 50 years and older
  • Sedentary lifestyle, defined as \< 150 min/wk moderate physical activity as assessed by CHAMPS questionnaire
  • Neurocognitive Impairment (as assessed using the BRACE+
  • Prescribed HIV ART for ≥ 12 months, with no current use of older drugs with established mitochondrial toxicity
  • Able to speak, read, and write in English
  • Willingness to participate in all study procedures

Exclusion

  • Diagnosis of mitochondrial disease
  • Active substance abuse or factors preventing compliance or safety
  • Uncontrolled hypertension, defined as resting BP \> 150/90 mmHG
  • Chronic kidney disease
  • Severe cardiac disease, including NYHA Class III or IV congestive heart failure, clinically significant aortic stenosis, history of cardiac arrest, use of a cardiac defibrillator, or uncontrolled angina
  • Acute myocardial infarction identified by medical history and ECG
  • Pulmonary disease requiring the use of supplemental oxygen
  • Poorly controlled diabetes
  • Neuropsychologically Intact
  • Orthopedic problems that limit ability to perform exercise
  • Simultaneous participation in another intervention trial

Key Trial Info

Start Date :

February 5 2024

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 1 2028

Estimated Enrollment :

60 Patients enrolled

Trial Details

Trial ID

NCT05965518

Start Date

February 5 2024

End Date

December 1 2028

Last Update

August 8 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Alabama at Birmingham

Birmingham, Alabama, United States, 35205